Completed
Hepatic impairment continued...
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Anticoagulation in High Bleeding Risk Cancer Patients - Dr Nolukholo Ncete
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Introduction continued...
- 3 Incidental VTE's
- 4 Cancer-associated risk factors for VTE
- 5 What the management may look like?
- 6 LMWH versus VKA
- 7 LMWH versus DOACs
- 8 Edoxaban
- 9 Apixaban
- 10 Considerations prior to prescribing DOACs in CAT
- 11 Thrombocytopenia continued...
- 12 Renal impairment & LMWH
- 13 Dosing recommendations according to creatinine clearance in mL/min
- 14 GIT/GU malignancy
- 15 Hepatic impairment continued...
- 16 Use of antiplatelet agents
- 17 Low body weight
- 18 Abnormal uterine bleeding
- 19 Intracranial lesions
- 20 The role of IVC filters
- 21 Mechanical prophylaxis
- 22 When to measure DOACs?
- 23 DOAC testing continued...
- 24 Monitoring of patients on LMWH
- 25 Warfarin initiation
